Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

BACKGROUND: In SMILE-4 (the Survival of Myocardial Infarction Long-term Evaluation 4 study), zofenopril + acetylsalicylic acid (ASA) was superior to ramipril + ASA in reducing the occurrence of major cardiovascular events in patients with left ventricular dysfunction following acute myocardial infar...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Borghi, Claudio, Ambrosioni, Ettore, Omboni, Stefano, Cicero, Arrigo FG, Bacchelli, Stefano, Esposti, Daniela Degli, Novo, Salvatore, Vinereanu, Dragos, Ambrosio, Giuseppe, Reggiardo, Giorgio, Zava, Dario
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709649/
https://ncbi.nlm.nih.gov/pubmed/23882152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S43138
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires